Clues Pointing TO This Diagnosis

Asymmetric onset in the right hand — asymmetric motor signs are characteristic of Parkinson's disease and help distinguish it from atypical/symmetric parkinsonism
Resting "pill-rolling" tremor at 4–6 Hz — a classic slow resting tremor is a core cardinal feature and typical of PD rather than essential tremor
Rigidity (morning stiffness) — rigidity is one of the additional cardinal motor features supporting parkinsonism
Bradykinesia implied by shuffling, smaller steps — bradykinesia is the mandatory core feature required to diagnose parkinsonism
Shuffling gait with reduced step length — gait impairment reflects the akinetic-rigid component of PD
Masked/hypomimic facies ("mask-like, less reactive") — reduced facial expression is a classic bradykinetic sign of PD
Micrographia (smaller handwriting) — progressively small handwriting reflects bradykinesia and is a well-recognized PD sign
Gradual, insidious progression over a year — slow onset favors idiopathic PD over rapidly progressive atypical syndromes
Robust improvement with carbidopa-levodopa — a dramatic dopaminergic response is a supportive diagnostic criterion for PD
Autonomic features (constipation, orthostatic drops) — nonmotor autonomic dysfunction is a recognized part of the PD spectrum

Why It's NOT the Similar Diseases

NOT essential tremor — essential tremor is a bilateral action/kinetic tremor (worse with movement, interfering with drinking) without rigidity, bradykinesia, or levodopa response; Theodore has a resting pill-rolling tremor with bradykinesia and rigidity
NOT drug-induced parkinsonism — this follows dopamine-blocking drugs (antipsychotics, metoclopramide), is typically symmetric, and improves with drug withdrawal; there is no such exposure and his onset is asymmetric
NOT progressive supranuclear palsy — PSP causes early falls, vertical gaze palsy, symmetric axial rigidity, and poor levodopa response; Theodore has asymmetric onset with strong levodopa response
NOT multiple system atrophy — MSA features early, severe autonomic failure, cerebellar signs, and a poor/short-lived levodopa response; his dopaminergic response is robust
NOT dementia with Lewy bodies — DLB presents with prominent early cognitive decline, fluctuations, and visual hallucinations that precede or accompany motor signs; Theodore's picture is a motor-predominant onset

Differential Diagnosis List

Essential tremor — ruled out by resting (not action) tremor with bradykinesia, rigidity, and levodopa response
Drug-induced parkinsonism — ruled out by absence of causative dopamine-blocking medication and asymmetric presentation
Progressive supranuclear palsy — ruled out by absence of early falls/vertical gaze palsy and by strong levodopa response
Multiple system atrophy — ruled out by robust levodopa response and lack of early severe autonomic/cerebellar predominance
Dementia with Lewy bodies — ruled out by motor-predominant onset without early dementia, fluctuations, or visual hallucinations

Key Distinguishing Test

Parkinson's disease is a clinical diagnosis: parkinsonism (bradykinesia plus rest tremor and/or rigidity) with supportive features and no red flags for an alternative cause; a dramatic response to carbidopa-levodopa strongly supports it.
When parkinsonism is uncertain—most often to separate PD from essential tremor—a dopamine transporter SPECT (DaT scan) can demonstrate reduced presynaptic striatal dopamine uptake, but it cannot distinguish PD from atypical parkinsonian syndromes and is not routinely required.

Board Note

The core motor tetrad is resting tremor, rigidity, bradykinesia, and (later) postural instability; asymmetry and a clear levodopa response are key clinical clues
Carbidopa-levodopa is the most effective first-line therapy for motor symptoms and is preferred initial therapy in older patients (>65) and those with significant motor disability; MAO-B inhibitors or dopamine agonists are alternatives in younger, milder patients
Dopamine agonists carry a higher risk of impulse-control disorders (gambling, hypersexuality, compulsive shopping/eating) and of hallucinations, especially in older adults; levodopa carries a higher long-term risk of dyskinesias and motor fluctuations
Nonmotor symptoms often need nondopaminergic treatment—SSRIs for depression, cholinesterase inhibitors for cognition, and management of constipation and orthostatic hypotension; exercise and physical, occupational, and speech therapy complement drug therapy
Refer to a specialist for deep brain stimulation (or levodopa-carbidopa intestinal gel) when patients have medication-responsive symptoms but disabling motor fluctuations, "off" periods, or medication-refractory tremor/dyskinesias

“Theodore’s Story”